Professional Documents
Culture Documents
Ih Chap 9 Mategas BSMT 3 A
Ih Chap 9 Mategas BSMT 3 A
Other Major
Blood Groups
Asmiana A. Mategas BSMT 3-A
BLOOD BANK CHAP 8
MN or MNSs system
1927 - Landsteiner and Levine discovered from
Biochemistry
GPA GPB
carry M and N antigens carry S, s, and U antigens
has 131 amino acids has 72 amino acids
Most O-linked carbohydrate structures are Most O-linked carbohydrate structures are
branched tetrasaccharides containing one GalNAc, branched tetrasaccharides containing one GalNAc,
one Gal, and two NeuNAc (sialic acid) one Gal, and two NeuNAc (sialic acid)
associates with protein band 3 associated with the Rh protein and Rh-associated
expressed on renal endothelium and epithelium glycoprotein complex
expressed on renal endothelium and epithelium
BLOOD BANK CHAP 8
Biochemistry
BLOOD BANK CHAP 8
Genetics
Chromosome 4 ; 4q28-q31
Antigens
M and N Antigens
Determinants are carried on glycophorin A
(GPA)
M - serine at position 1 and glycine at
position 5
N - leucine at position 1 and glutamic acid at
position 5
about 106 copies of GPA per RBC
Well developed at birth
easily destroyed by ficin, papain, bromelin,
trypsin and pronase
Antibodies are heterogeneous
BLOOD BANK CHAP 8
Antigens
S and s Antigens
carried on glycophorin B (GPB)
S - has methionine at position 29 of GPB
s - has threonine at position 29 of GPB
fewer copies of GPB than GPA per RBC
about 1.5 times more copies of GPB on S+s– RBCs
than on S–s+ RBCs
Well developed at birth
Antigens are less easily degraded by enzymes
BLOOD BANK CHAP 8
MNSs Antibodies
Anti-M Anti-N Anti-S and
Naturally occurring saline similar to anti-M Anti-s
agglutinins that react below a cold-reactive IgM or IgG
37°C saline agglutinin that does Most are IgG, reactive at
Do not bind complement not bind complement or react 37°C and the antiglobulin
Do not react with enzyme- with enzyme-treated RBCs test
treated RBCs made by individuals whose RBCs seen less often than Anti-M
may react better with M+N– type M+N– and S+ or s+ but are more likely to be
RBCs (genotype MM) than with Rare examples are pH- or clinically significant
M+N+ RBCs (genotype MN) glucose-dependent May bind complement,
Some are pH-dependent, less common than anti-M associated with severe HTRs
reacting best at pH 6.5 rare cases of mild HDFN with hemoglobinuria and HDFN
rarely causes HTRs, decreased A potent anti-N can be made by
red cell survival, or HDFN the rare individual whose RBCs
type M+N–S–s– because they
lack both N and GPB that has
‘N’ activity
BLOOD BANK CHAP 8
1927
028: Globoside Anti-P became anti-P1; the P+ phenotype became P1; the P–
Blood Group phenotype became P2; and the rare P null individual became p
1959
System (GLOB) Matson and coworkers described a new antigen, Pk
& related
antigens
BLOOD BANK CHAP 8
Biochemistry
Genetics
A4GALT (alpha 1,4-galactosyltransferase)
gene encoding the enzyme (4-α-galactosyltransferase (Gb3 or Pk synthase)) responsible
for the synthesis of Pk
B3GALNT1
encoding the 3-β-Nacetylgalactosaminyltransferase (Gb4 synthase) responsible for
converting Pk to P
Several mutations in both genes have been identified that result in the p and Pk
phenotypes
A polymorphism in the Pk synthase was recently identified that ties the P1 and Pk
antigens together
P1PK gene (located at chromosome 22q11.2) and the P gene (located at chromosome
3q26.1) are inherited independently
gene for the synthesis of LKE has not yet been cloned
BLOOD BANK CHAP 8
P1 P2
Pk1 Pk2
A very rare phenotype A very rare phenotype
P1 and Pk antigen on RBC P2 and Pk antigen on RBCs
Have not been identified in secretions React with anti-P1 and anti-Pk React with anti-Pk but not with
but not with anti-P anti-P1 or anti-P
P null (P phenotype)
Extremely rare
RBCs are negative for P, P1, and
Pk antigen
Do not react with anti-P1, anti-
P, or anti-Pk
BLOOD BANK CHAP 8
P Antibodies
2 categories: clinically significant and potently hemolytic
Blood Group
gene encoding the transferase that converts i active straight
chains into I active branched chains has been cloned
I Antigens
I Antigens
Ii I/I1 i/I2
Represent developmental Detected in saliva by A characteristic of dividing
antigens on red cells hemagglutination inhibition cells present on a variety
and in many other ID (developed) of cell types including
Most adult cells, but
tissues lymphoblasts, fibroblasts,
not cord or adult i cells
Treatment of red cells I (fetal)
erythroblasts, and
with proteases or with Expressed on all human thymocytes
sialidase generally red cells
enhances expression of IT antigen
Ii antigens named by Booth et al.
expressed strongly on
cord cells, weakly on
normal adult cells, and
weaker still on adult i
cells
T - transition
BLOOD BANK CHAP 8
Ii Antibodies
Present in the sera of all adults
potent cold lymphocytotoxins, effective at killing B and T lymphocytes
Anti-I Autoanti-I
Most prevalent of autoantibodies production of autoanti-I may be stimulated by
Found in virtually all sera microorganisms carrying I-like antigen on their
Generally weak surface
Incubating tests in the cold enhances anti-I Found in the serum of many normal healthy
reactivity and helps confirm its identity individuals and is benign
not associated with HDFN because the antibody is weak, naturally occurring, saline-reactive IgM
IgM agglutinin with a titer less than 64 at 4°C
strong autoanti-I can mimic alloanti-I
BLOOD BANK CHAP 8
Ii Antibodies
Present in the sera of all adults
potent cold lymphocytotoxins, effective at killing B and T lymphocytes
Ii Antibodies
Present in the sera of all adults
potent cold lymphocytotoxins, effective at killing B and T lymphocytes
Anti-i Autoanti-i
found in the serum of patients with rare antibody that gives strong reactions with
infectious mononucleosis and occasionally cord RBCs and adult i RBCs and weaker reactions
causes haemolysis with adult I RBCs
Associated with immunodeficiency Most are IgM
associated with HDFN High-titer autoantibodies with a wide thermal
range may contribute to hemolysis
BLOOD BANK CHAP 8
Ii Antibodies
Present in the sera of all adults
potent cold lymphocytotoxins, effective at killing B and T lymphocytes
Anti-IT Anti-j
1965 - Curtain and coworkers; cold agglutinin in Reacts with protease- and sialidase-treated red
Melanesians that did not demonstrate classical I cells, but not with cells treated with endo-b-
or i specificity galactosidase
1966 - Booth and colleagues confirmed these Resembled most pathogenic anti-I and -i by
observations expressing the 9G4 idiotype, a characteristic of
Expressed strongly on cord cells, weakly on most antibodies encoded by a gene utilizing a V4- 34
adult cells, and very weakly on adult i cells sequence
Examples IgM and IgG anti-IT reacting
preferentially at 37°C (warm autoimmune
hemolytic anemia)
BLOOD BANK CHAP 8
Ii Antibodies
Present in the sera of all adults
potent cold lymphocytotoxins, effective at killing B and T lymphocytes
BLOOD BANK CHAP 8
Consists of 32 high-prevalence
and low-prevalence antigens
Biochemistry
Genetics
KELL Xk protein
erythroid tissues, brain, lymphoid organs,
Antigens
heart, and skeletal muscle
Ko - null phenotype
Arises from homozygosity for a silent gene at
the KEL locus
Ku antigen
present on all cells
K18
only Kell antigen not shown to be inherited
TOU (KEL26)
high frequency antigen absent from Ko cells
BLOOD BANK CHAP 8
KELL Antigens
K and k Antigens Kpa, Kpb, Kpc Jsa and Jsb Kx Antigen
Antigens Antigens
rated second only to D Present on all RBCs
in immunogenicity Kpa and Kpc are low- Jsa antigen except those of the
Well developed at birth prevalence mutations of antithetical to the rare McLeod phenotype
K - 10 to 11 weeks their high-prevalence high-prevalence
k - 6 to 7 weeks’ partner Kpb antigen Jsb
gestation Kpa gene is associated Jsa and Jsb were linked
Most anti-K appear to with suppression of to the Kell system when
be induced by pregnancy other Kell antigens on it was discovered that
and transfusion the same molecule, Ko RBCs were Js(a–b–)
Antibodies to k antigen including k and Jsb
are seldom encountered Kpc antigen is even
more rare
BLOOD BANK CHAP 8
KELL Antibodies
Anti-K Antibodies to Kpa, Jsa, and
Other Low-Prevalence Kell
Antibodies to Kpa, Jsa,
and Other Low-Prevalence
anti-K is the most common Antigens Kell Antigens
antibody seen in the blood rare rare
bank most often detected through Parallel anti-K in serologic
Usually IgG and reactive in unexpected incompatible characteristics and clinical
the antiglobulin phase crossmatches or cases of HDFN significance
made in response to antigen serologic characteristics and Easy to detect but difficult to
exposure through pregnancy and clinical significance of these work with
transfusion and can persist antibodies parallel anti-K Finding compatible units for
for many years original anti-Kpa was naturally transfusion can be difficult
Naturally occurring IgM occurring, but most antibodies
examples of anti-K are rare result from transfusion or
and have been associated with pregnancy
bacterial infections
Has been implicated in severe
HTRs
associated with severe HDFN
BLOOD BANK CHAP 8
KELL Antibodies
Ko Phenotype Anti-Ku (K5)
Immunized individuals with the
Lack expression of all Kell Ko phenotype typically make an
antigens antibody called anti-Ku (K5)
Have no membrane abnormality Appears to be a single
and survive normally in specificity and cannot be
circulation separated into components
Rare Has caused both HDFN and HTRs
BLOOD BANK CHAP 8
Antibodies
have marked depression of all other Kell antigens
associated with several mutations and deletions at the XK
locus
acanthocytic (having irregular shapes and protrusions)
with decreased deformability and reduced in vivo survival
have a variety of muscle and nerve disorders that,
together with the serologic and hematologic picture, are
collectively known as the McLeod syndrome
elevated serum creatinine phosphokinase levels of the MM
type
Lyon hypothesis - expression of Kx in women who are
carriers of the Mcleod phenotype
BLOOD BANK CHAP 8
1950
Named for Mr. Duffy who was found to have the first
008: Duffy described example of anti-Fya
Biocehmistry
reside on a glycoprotein of 336 amino acids and two N-glycosylation sites
amino acid at position 42 on Duffy glycoprotein:
Fya has glycine
Fyb has aspartic acid
BLOOD BANK CHAP 8
Genetics
1968
Duffy gene was linked to a visible, inherited
abnormality of chromosome 1
The gene is located near the centromere on the long
arm of chromosome 1 at position 1q23.2.
Duffy Blood Group Sysytem contains 4 alleles:
Fya
Fyb
Fy
Fyx
These alleles are responsible for the major
antigens and result in 4 common phenotypes:
Fy a+b+ = Ag (Fya and Fyb) Ab (none)
Fy a+b− = Ag (Fya) Ab (Anti-Fyb)
Fy a−b+ = Ag (Fyb) Ab (Anti-Fya)
Fy a−b− = Ag (none) Ab (Anti-Fya and Anti -Fyb
BLOOD BANK CHAP 8
DUFFY Antigens
Most important in routine blood bank serology are Fya and Fyb
Can be identified on fetal RBCs as early as 6 weeks gestational age and are well
developed at birth
There are about 13,000 sites Fya on Fy(a+b–) and 14,000 Fyb sites on Fy(a–b+) RBCs
Have been identified in other body tissues, including brain, colon, endothelium, lung,
spleen, thyroid, thymus, and kidney cells
Result from a Gly42Asp substitution within the Duffy glycoprotein
BLOOD BANK CHAP 8
Antibodies
phase
can activate complement
Because anti-Fya and anti-Fyb do not react with
enzyme-treated RBCs, this is a helpful technique
Anti-FyA when multiple antibodies are present
Anti-Fyb Have been associated with acute and delayed HTRs
Fyx Associated with HDFN that ranges from mild to
Fy3 Antigen and Antibody severe
Fy5 Antigen and Antibody Rare autoantibodies with mimicking Fya and Fyb
specificity have been reported
BLOOD BANK CHAP 8
DUFFY Antibodies
Anti-FyA Anti-Fyb Fyx
found as a single specificity Often consisting entirely of Does not produce a distinct
or in a mixture of antibodies IgG1 antigen but rather is an
usually IgG, mostly IgG1 20 times less common than inherited weak form of Fyb
Occurs three times less anti-Fya and often occurs in that reacts with some examples
frequently than anti-K combination with other of anti-Fyb
commonly detected after 6 antibodies Individuals with Fyx may type
months and even more so after stimulated by pregnancy and Fy(b–), but their RBCs adsorb
5 years transfusion, and by and elute anti-Fyb
intrauterine transfusion in There is no anti-Fyx
the mother
Some anti - Fyb bind
complement
BLOOD BANK CHAP 8
DUFFY Antibodies
Fy3 Antigen and Antibody Fy5 Antigen and
1971 - anti-Fy3 was found in the serum Antibody
Fy(a–b–)
Because it was an inseparable anti- 1973 - Colledge and coworkers
FyaFyb, it was thought to react with
discovered anti-Fy5 in the
an antigenic determinant or precursor
common to both Fya and Fyb
serum of an Fy(a–b–)
Ab molecular structure of Fy5 is
rare antibody made by Fy(a–b–) not known
individuals who lack the Duffy Expressed equally strongly on
glycoprotein red cells of adults and
present on all red cells apart
from those of the Fy(a– b–)
newborns
phenotype DARC appears to be part of a
potentially haemolytic and has protein complex that contains
been responsible for immediate and the Rh proteins
delayed HTRs , including
intravascular haemolysis in an
acute reaction and hyperhemolysis
in a patient with sickle cell
disease
BLOOD BANK CHAP 8
Fy(a– b– ) phenotype
Resistant to infection by the malarial parasite
Discovered in 1950s
consisting of only three antigens
1951 - Allen and colleagues reported finding an
009: KIDD
antibody in the serum of Mrs. Kidd, whose infant
had HDFN
Blood Group anti-Jka - reacted with 77% of Bostonians
Biochemistry
Genetics
Jk locus is on chromosome 18 at position 18q12.3.
Gene SLC14A1
a member of the urea transporter gene family
Jka/Jkb polymorphism is associated with an amino acid
substitution at position 280
the silent Jk allele can arise from mutations in both the
Jka and Jkb alleles
BLOOD BANK CHAP 8
KIDD Antigens
KIDD Antibodies
IgG and warm-reactive
LABILE in storage
Can bind with complement
1945
anti-Lua was found in the serum of a patient with SLE
Named Lutheran for the donor
1956
Cutbush and Chanarin described anti-Lub
Blood Group
Crawford and colleagues described the first Lu(a–
b–)phenotype
LUTHERAN Antigens
LUTHERAN Antibodies
LUTHERAN Phenotypes
THANK YOU!